Developer docs
API playgroundTry for free, no card

Search company profiles

Cardea Health

Full company profile

uuid0028693

Namestring
Cardea Health
Legal namestring
Cardea Health Inc.
Websiteurl
cardeahealth.io
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Cardea Health Inc. is a Canadian AI-healthtech company founded in 2021 and headquartered in Mississauga, Ontario, that builds the FLOW platform, a cardiology-focused data infrastructure designed to structure longitudinal outpatient EMR data and power clinical trial pre-screening, real-world evidence (RWE) generation, and implementation science. The platform is delivered through three integrated modules: ScreenFLOW for AI-powered patient pre-screening, SearchFLOW for data analysis and cohort identification, and WorkFLOW for consolidated patient data visualization. The underlying technology combines a purpose-built multi-agent (third-generation agentic) AI architecture with NLP, OCR, and a proprietary 250+ term cardiometabolic lexicon trained on real-world clinical data, with a "Reviewer in the Loop" human-in-the-loop audit layer. Cardea reports quantified performance versus manual processes: 98.2% medication identification accuracy (vs 87.2% human), 86% complex diagnosis accuracy (vs ~70% manual), 15-second patient reviews (vs 15 minutes), a 33-day faster patient identification cycle, and a 50% reduction in pre-screening spend.

Cardea serves two primary customer segments: pharmaceutical sponsors running Phase II-IV cardiometabolic and adjacent clinical trials (named engagements include Novo Nordisk, Amgen, Sanofi, and Novartis) and outpatient clinical trial site networks across North America (Heart Health Institute in Ontario, SiteCentric, Areti Health, and clinics reachable through the QHR Technologies Accuro EMR marketplace). Therapeutic areas include ASCVD, obesity, elevated lipoprotein(a), MASH, diabetes, hypertension, heart failure, kidney disease, COPD, and several oncology indications.

The business model is enterprise SaaS-like with recurring subscription/service revenue from pharma sponsors for clinical trial pre-screening and RWE programs, plus site network engagements. Pricing is quote-based (demo-led) and not publicly disclosed. The company has raised approximately $1.325M CAD to date ($975K pre-seed in October 2022 and a $350K non-dilutive FedDev Ontario grant in January 2026), operates with 1-10 employees, and has no parent company, subsidiaries, or public listing.

Short descriptiontext

Cardea Health is a Canadian AI-healthtech company building a cardiology-focused data platform that structures outpatient EMR data to accelerate clinical trial patient recruitment and generate real-world evidence for pharmaceutical sponsors across North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, real-world evidence, cardiology data platform, patient pre-screening, clinical AI software
Industry2 codes
PRIMARYHLACAOAK
Patient Recruitment, Retention & Engagement for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Technology
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Patient Recruitment Services
TypeSubscription Recurring
Description

Cardea Health provides AI-powered patient pre-screening and recruitment services to pharmaceutical sponsors, helping reduce patient acquisition costs and accelerate trial timelines. Services include feasibility studies, cohort building, and protocol-ready patient lists for Phase II-IV clinical trials.

cardeahealth.io
2Real-World Evidence (RWE) Programs
TypeSubscription Recurring
Description

Generating real-world evidence from outpatient EMR data for sponsors including Novo Nordisk, Amgen, and Sanofi. Supports outcomes research, treatment pathway analyses, and care-gap measurement.

cardeahealth.io
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cardea Health operates the FLOW platform, an AI-powered cardiology-centric data infrastructure that structures longitudinal outpatient EMR data (both structured and unstructured) to support clinical trial patient pre-screening, real-world evidence (RWE) generation, and outpatient cardiology decision-making. The platform combines proprietary multi-agent AI, NLP, OCR, and a 250+ term cardiometabolic lexicon with a "Reviewer in the Loop" workflow to deliver protocol-ready patient cohorts and audit-ready outputs for pharmaceutical sponsors and clinical trial site networks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 50% reduction in patient acquisition costs for clinical trials
+4 more records
Product overview1 text field

Cardea Health offers FLOW, a unified AI-powered cardiology data platform consisting of three integrated modules: ScreenFLOW for AI-powered patient pre-screening, SearchFLOW for data analysis and cohort identification, and WorkFLOW for consolidated patient data visualization. The platform structures longitudinal outpatient EMR data (both structured and unstructured) to power clinical trials, real-world evidence (RWE) generation, and implementation science initiatives across outpatient cardiology clinics in North America. The system leverages proprietary NLP and multi-agent AI to identify eligible patients in seconds, achieving 98.2% medication identification accuracy and 86% complex diagnosis accuracy, while reducing pre-screening costs by 50%.

Product and service1 record
1FLOW Platform
CategoryClinical Trial Technology
Description

Unified AI-powered cardiology-centric data platform that structures longitudinal outpatient EMR data to power clinical trial pre-screening, real-world evidence generation, and implementation science. Designed for pharmaceutical sponsors, clinical trial site networks, and outpatient cardiology clinics across North America.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-23
Description

AI-powered partnership between Cardea Health and Areti Health to reshape clinical trials with smarter recruitment and faster randomization. The collaboration combines Cardea's AI patient pre-screening capabilities with Areti's technology to improve trial efficiency, cut costs, and boost diversity in clinical trials.

Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2026-01-23
Description

Ecosystem partner working with Cardea Health on clinical research site network collaboration. SiteCentric shares Cardea's belief that the future of clinical research depends on better data access and smarter workflows.

3QHR Technologies (Accuro)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-09-15
Description

Cardea Health became an Accuro Marketplace Vendor, offering cardiology solutions on QHR Technologies' Accuro EMR platform. This integration enables Cardea to reach outpatient clinics in Canada using the Accuro electronic medical records system.

cardeahealth.io
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-01
Description

Innovative partnership between Novartis, Cardea Health Inc., and Heart Health Institute for ASCVD management in Ontario. The collaboration focuses on cardiovascular disease management with data showing LDL decrease from baseline 2.5 to 1.2 after one visit. Data collected over 6 months with 1 nurse practitioner seeing average 9 ASCVD patients per day.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Heart Health Institute operates 2 outpatient clinics with 11 cardiologists and is where Cardea Health founders Naveed Ahmad and Dr. Andrew Yadegari met. The partnership involves co-founding Cardea Health and ongoing collaboration on ASCVD management programs with Novartis.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Syneos Health is a biopharmaceutical solutions organization offering clinical development services and real-world evidence. Comparable customer overlap with pharma sponsors and similar RWE/trial workflows, but as a large diversified CRO rather than a focused AI tool.

TypeDirect peer
Description

Medable provides a clinical trial technology platform spanning eCOA, ePRO, telehealth, and decentralized trial workflows. Comparable as a clinical trial SaaS vendor serving pharma sponsors, though broader and more patient-centric than Cardea's EMR analytics focus.

TypeBroad incumbent
Description

Flatiron Health (acquired by Roche) provides real-world evidence and EHR-derived clinical data primarily for oncology research and care delivery. Comparable as an RWE platform serving pharma sponsors, though oncology-focused and at much larger scale.

TypeDirect peer
Description

Castor offers an eClinical platform for decentralized and hybrid clinical trials with eCRF, ePRO, and eConsent modules. Comparable as a clinical trial data platform serving pharma and CROs, though more focused on data capture than patient identification.

TypeBroad incumbent
Description

ICON plc is a global CRO with significant clinical trial services and site network operations. Overlaps with Cardea's trial services and real-world evidence offerings but as a broad incumbent rather than an AI-native specialist.

TypeBroad incumbent
Description

IQVIA is the largest CRO with E360 and other AI-driven clinical trial analytics, real-world evidence, and patient identification capabilities. Overlaps with Cardea's pharma sponsor GTM and RWE focus, but operates across all therapeutic areas and geographies.

TypeBroad incumbent
Description

ConcertAI provides AI-powered real-world evidence and clinical trial solutions for life sciences, particularly in oncology. Comparable in RWE generation and pharma customer base, but broader therapeutic scope and far larger scale than Cardea.

8Deep 6 AI
TypeDirect peer
Description

Deep 6 AI builds AI-driven patient matching and cohort identification for clinical trials using structured and unstructured EMR data, directly comparable to Cardea's ScreenFLOW and SearchFLOW modules. Both target pharma sponsors and site networks to accelerate enrollment.

9Antidote (Trial Library)
TypeDirect peer
Description

Antidote (now part of Trial Library) is a clinical trial recruitment and patient matching platform connecting sponsors with eligible patients. Overlapping pre-screening and recruitment workflow with Cardea's ScreenFLOW, although more patient-facing versus Cardea's EMR-first approach.

10Mendel
TypeDirect peer
Description

Mendel applies AI to clinical research and patient-trial matching across multiple therapeutic areas, with a comparable enterprise GTM to pharma sponsors. Its focus on automating chart review and eligibility mirrors Cardea's core value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cardea Health

Clinical Trial Technologycardeahealth.io

Cardea Health is a Canadian AI-healthtech company building a cardiology-focused data platform that structures outpatient EMR data to accelerate clinical trial patient recruitment and generate real-world evidence for pharmaceutical sponsors across North America.

What Cardea Health does

Cardea Health Inc. is a Canadian AI-healthtech company founded in 2021 and headquartered in Mississauga, Ontario, that builds the FLOW platform, a cardiology-focused data infrastructure designed to structure longitudinal outpatient EMR data and power clinical trial pre-screening, real-world evidence (RWE) generation, and implementation science. The platform is delivered through three integrated modules: ScreenFLOW for AI-powered patient pre-screening, SearchFLOW for data analysis and cohort identification, and WorkFLOW for consolidated patient data visualization. The underlying technology combines a purpose-built multi-agent (third-generation agentic) AI architecture with NLP, OCR, and a proprietary 250+ term cardiometabolic lexicon trained on real-world clinical data, with a "Reviewer in the Loop" human-in-the-loop audit layer. Cardea reports quantified performance versus manual processes: 98.2% medication identification accuracy (vs 87.2% human), 86% complex diagnosis accuracy (vs ~70% manual), 15-second patient reviews (vs 15 minutes), a 33-day faster patient identification cycle, and a 50% reduction in pre-screening spend.

Cardea serves two primary customer segments: pharmaceutical sponsors running Phase II-IV cardiometabolic and adjacent clinical trials (named engagements include Novo Nordisk, Amgen, Sanofi, and Novartis) and outpatient clinical trial site networks across North America (Heart Health Institute in Ontario, SiteCentric, Areti Health, and clinics reachable through the QHR Technologies Accuro EMR marketplace). Therapeutic areas include ASCVD, obesity, elevated lipoprotein(a), MASH, diabetes, hypertension, heart failure, kidney disease, COPD, and several oncology indications.

The business model is enterprise SaaS-like with recurring subscription/service revenue from pharma sponsors for clinical trial pre-screening and RWE programs, plus site network engagements. Pricing is quote-based (demo-led) and not publicly disclosed. The company has raised approximately $1.325M CAD to date ($975K pre-seed in October 2022 and a $350K non-dilutive FedDev Ontario grant in January 2026), operates with 1-10 employees, and has no parent company, subsidiaries, or public listing.

Cardea Health firmographics

Firmographics
Name
Cardea Health
Legal name
Cardea Health Inc.
Website
https://cardeahealth.io
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Cardea Health is a Canadian AI-healthtech company building a cardiology-focused data platform that structures outpatient EMR data to accelerate clinical trial patient recruitment and generate real-world evidence for pharmaceutical sponsors across North America.
Ownership category
akta.pro rank

Cardea Health industry classification

Industry
Product category
Clinical Trial Technology
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAK
Patient Recruitment, Retention & Engagement for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial recruitment
  • Real-world evidence
  • Cardiology data platform
  • Patient pre-screening
  • Clinical AI software

Where Cardea Health is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Cardea Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Clinical Trial Patient Recruitment Services: Cardea Health provides AI-powered patient pre-screening and recruitment services to pharmaceutical sponsors, helping reduce patient acquisition costs and accelerate trial timelines. Services include feasibility studies, cohort building, and protocol-ready patient lists for Phase II-IV clinical trials.
  2. Real-World Evidence (RWE) Programs: Generating real-world evidence from outpatient EMR data for sponsors including Novo Nordisk, Amgen, and Sanofi. Supports outcomes research, treatment pathway analyses, and care-gap measurement.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Cardea Health product offering

Product offering

Core offering

Cardea Health operates the FLOW platform, an AI-powered cardiology-centric data infrastructure that structures longitudinal outpatient EMR data (both structured and unstructured) to support clinical trial patient pre-screening, real-world evidence (RWE) generation, and outpatient cardiology decision-making. The platform combines proprietary multi-agent AI, NLP, OCR, and a 250+ term cardiometabolic lexicon with a "Reviewer in the Loop" workflow to deliver protocol-ready patient cohorts and audit-ready outputs for pharmaceutical sponsors and clinical trial site networks.

Product overview

Cardea Health offers FLOW, a unified AI-powered cardiology data platform consisting of three integrated modules: ScreenFLOW for AI-powered patient pre-screening, SearchFLOW for data analysis and cohort identification, and WorkFLOW for consolidated patient data visualization. The platform structures longitudinal outpatient EMR data (both structured and unstructured) to power clinical trials, real-world evidence (RWE) generation, and implementation science initiatives across outpatient cardiology clinics in North America. The system leverages proprietary NLP and multi-agent AI to identify eligible patients in seconds, achieving 98.2% medication identification accuracy and 86% complex diagnosis accuracy, while reducing pre-screening costs by 50%.

Differentiator

Problem solved

Functional benefit

Products and services

  • FLOW Platform Unified AI-powered cardiology-centric data platform that structures longitudinal outpatient EMR data to power clinical trial pre-screening, real-world evidence generation, and implementation science. Designed for pharmaceutical sponsors, clinical trial site networks, and outpatient cardiology clinics across North America.

Quantifiable outcome

  • 50% reduction in patient acquisition costs for clinical trials
  • +4 more outcomes

Companies that use Cardea Health

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Cardea Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Cardea Health partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and supporting.

  • Areti HealthcoreStrategic or Co-development Partner · 23 January 2026AI-powered partnership between Cardea Health and Areti Health to reshape clinical trials with smarter recruitment and faster randomization. The collaboration combines Cardea's AI patient pre-screening capabilities with Areti's technology to improve trial efficiency, cut costs, and boost diversity in clinical trials.
  • SiteCentricsupportingGTM or Marketing Partner · 23 January 2026Ecosystem partner working with Cardea Health on clinical research site network collaboration. SiteCentric shares Cardea's belief that the future of clinical research depends on better data access and smarter workflows.
  • QHR Technologies (Accuro)coreTechnology or Integration · 15 September 2023Cardea Health became an Accuro Marketplace Vendor, offering cardiology solutions on QHR Technologies' Accuro EMR platform. This integration enables Cardea to reach outpatient clinics in Canada using the Accuro electronic medical records system.
  • NovartiscoreStrategic or Co-development Partner · 1 March 2023Innovative partnership between Novartis, Cardea Health Inc., and Heart Health Institute for ASCVD management in Ontario. The collaboration focuses on cardiovascular disease management with data showing LDL decrease from baseline 2.5 to 1.2 after one visit. Data collected over 6 months with 1 nurse practitioner seeing average 9 ASCVD patients per day.
  • Heart Health InstitutecoreStrategic or Co-development Partner · 1 January 2021Heart Health Institute operates 2 outpatient clinics with 11 cardiologists and is where Cardea Health founders Naveed Ahmad and Dr. Andrew Yadegari met. The partnership involves co-founding Cardea Health and ongoing collaboration on ASCVD management programs with Novartis.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Cardea Health competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Syneos Health is a biopharmaceutical solutions organization offering clinical development services and real-world evidence. Comparable customer overlap with pharma sponsors and similar RWE/trial workflows, but as a large diversified CRO rather than a focused AI tool.
  • Flatiron Health: Flatiron Health (acquired by Roche) provides real-world evidence and EHR-derived clinical data primarily for oncology research and care delivery. Comparable as an RWE platform serving pharma sponsors, though oncology-focused and at much larger scale.
  • ICON plc: ICON plc is a global CRO with significant clinical trial services and site network operations. Overlaps with Cardea's trial services and real-world evidence offerings but as a broad incumbent rather than an AI-native specialist.
  • IQVIA: IQVIA is the largest CRO with E360 and other AI-driven clinical trial analytics, real-world evidence, and patient identification capabilities. Overlaps with Cardea's pharma sponsor GTM and RWE focus, but operates across all therapeutic areas and geographies.
  • ConcertAI: ConcertAI provides AI-powered real-world evidence and clinical trial solutions for life sciences, particularly in oncology. Comparable in RWE generation and pharma customer base, but broader therapeutic scope and far larger scale than Cardea.

Direct peers

  • Medable: Medable provides a clinical trial technology platform spanning eCOA, ePRO, telehealth, and decentralized trial workflows. Comparable as a clinical trial SaaS vendor serving pharma sponsors, though broader and more patient-centric than Cardea's EMR analytics focus.
  • Castor: Castor offers an eClinical platform for decentralized and hybrid clinical trials with eCRF, ePRO, and eConsent modules. Comparable as a clinical trial data platform serving pharma and CROs, though more focused on data capture than patient identification.
  • Deep 6 AI: Deep 6 AI builds AI-driven patient matching and cohort identification for clinical trials using structured and unstructured EMR data, directly comparable to Cardea's ScreenFLOW and SearchFLOW modules. Both target pharma sponsors and site networks to accelerate enrollment.
  • Antidote (Trial Library): Antidote (now part of Trial Library) is a clinical trial recruitment and patient matching platform connecting sponsors with eligible patients. Overlapping pre-screening and recruitment workflow with Cardea's ScreenFLOW, although more patient-facing versus Cardea's EMR-first approach.
  • Mendel: Mendel applies AI to clinical research and patient-trial matching across multiple therapeutic areas, with a comparable enterprise GTM to pharma sponsors. Its focus on automating chart review and eligibility mirrors Cardea's core value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cardea Health social profiles

Digital presence

Cardea Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cardea Health leadership team

Management profile

Number of profiles

Profiles3 records

Cardea Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cardea Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardea Health

What does Cardea Health do?

Cardea Health operates the FLOW platform, an AI-powered cardiology-centric data infrastructure that structures longitudinal outpatient EMR data (both structured and unstructured) to support clinical trial patient pre-screening, real-world evidence (RWE) generation, and outpatient cardiology decision-making. The platform combines proprietary multi-agent AI, NLP, OCR, and a 250+ term cardiometabolic lexicon with a "Reviewer in the Loop" workflow to deliver protocol-ready patient cohorts and audit-ready outputs for pharmaceutical sponsors and clinical trial site networks.

Is Cardea Health a public or private company?

Cardea Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cardea Health founded?

Cardea Health was founded in 2021. It employs 11 to 50 people.

Where is Cardea Health based?

Cardea Health is headquartered in Toronto, Canada, in the North America region.

How does Cardea Health make money?

Two revenue lines are on record. Clinical Trial Patient Recruitment Services are the primary driver. The others are real-World Evidence (RWE) Programs.

Who are Cardea Health's main competitors?

Broad incumbents on record are Syneos Health, Flatiron Health, ICON plc, IQVIA and ConcertAI. Direct peers are Medable, Castor, Deep 6 AI, Antidote (Trial Library) and Mendel.

Does Cardea Health have an API?

No public API is recorded for Cardea Health.

What industry is Cardea Health in?

Cardea Health's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLACAOAK, Patient Recruitment, Retention & Engagement for Trials, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 518 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals